This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2025 Oct;214(4):352-353.

doi: 10.1097/JU.0000000000004672. Epub 2025 Jul 18.

Editorial Comment

Brian J Linder¹

Affiliations

PMID: 40679048
DOI: 10.1097/JU.0000000000004672

Comment

Editorial Comment

Brian J Linder. J Urol. 2025 Oct.

. 2025 Oct;214(4):352-353.

doi: 10.1097/JU.0000000000004672. Epub 2025 Jul 18.

Author

Brian J Linder¹

Affiliation

¹ Department of Urology, Mayo Clinic, Rochester, Minnesota.

PMID: 40679048
DOI: 10.1097/JU.0000000000004672

No abstract available

PubMed Disclaimer

Comment on

The Efficacy and Safety Between Intradetrusor OnabotulinumtoxinA Injection and Combined Pharmacotherapy in Patients With Refractory Overactive Bladder: A Randomized Controlled Trial.
Hsieh MH, Hwang JC, Su TH, Lau HH. Hsieh MH, et al. J Urol. 2025 Oct;214(4):344-353. doi: 10.1097/JU.0000000000004660. Epub 2025 Jul 1. J Urol. 2025. PMID: 40590342 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources